Literature DB >> 19349371

Reactive oxygen species mediate liver injury through parenchymal nuclear factor-kappaB inactivation in prolonged ischemia/reperfusion.

Laura Llacuna1, Montserrat Marí, Josep M Lluis, Carmen García-Ruiz, José C Fernández-Checa, Albert Morales.   

Abstract

Nuclear factor (NF)-kappaB participates in ischemia/reperfusion (I/R) hepatic signaling, stimulating both protective mechanisms and the generation of inflammatory cytokines. After analyzing NF-kappaB activation during increasing times of ischemia in murine I/R, we observed that the nuclear translocation of p65 paralleled Src and IkappaB tyrosine phosphorylation, which peaked after 60 minutes of ischemia. After extended ischemic periods (90 to 120 minutes) however, nuclear p65 levels were inversely correlated with the progressive induction of oxidative stress. Despite this profile of NF-kappaB activation, inflammatory genes, such as tumor necrosis factor (TNF) and interleukin (IL)-1beta, predominantly induced by Kupffer cells, increased throughout time during ischemia (30 to 120 minutes), whereas protective NF-kappaB-dependent genes, such as manganese superoxide dismutase (Mn-SOD), expressed in parenchymal cells, decreased. Consistent with this behavior, gadolinium chloride pretreatment abolished TNF/IL-1beta up-regulation during ischemia without affecting Mn-SOD levels. Interestingly, specific glutathione (GSH) up-regulation in hepatocytes by S-adenosylmethionine increased Mn-SOD expression and protected against I/R-mediated liver injury despite TNF/IL-1beta induction. Similar protection was achieved by administration of the SOD mimetic MnTBAP. In contrast, indiscriminate hepatic GSH depletion by buthionine-sulfoximine before I/R potentiated oxidative stress and decreased both nuclear p65 and Mn-SOD expression levels, increasing TNF/IL-1beta up-regulation and I/R-induced liver damage. Thus, the divergent role of NF-kappaB activation in selective liver cell populations underlies the dichotomy of NF-kappaB in hepatic I/R injury, illustrating the relevance of specifically maintaining NF-kappaB activation in parenchymal cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19349371      PMCID: PMC2671266          DOI: 10.2353/ajpath.2009.080857

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

1.  Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury.

Authors:  Laura Llacuna; Montserrat Marí; Carmen Garcia-Ruiz; José C Fernandez-Checa; Albert Morales
Journal:  Hepatology       Date:  2006-09       Impact factor: 17.425

Review 2.  Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time.

Authors:  Gioacchino Natoli; Simona Saccani; Daniela Bosisio; Ivan Marazzi
Journal:  Nat Immunol       Date:  2005-05       Impact factor: 25.606

Review 3.  Intracellular survival pathways in the liver.

Authors:  Tom Luedde; Christian Trautwein
Journal:  Liver Int       Date:  2006-12       Impact factor: 5.828

4.  Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells.

Authors:  Allan Tsung; Rosemary A Hoffman; Kunihiko Izuishi; Nathan D Critchlow; Atsunori Nakao; Meagan H Chan; Michael T Lotze; David A Geller; Timothy R Billiar
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

5.  Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury.

Authors:  Tom Luedde; Ulrike Assmus; Torsten Wüstefeld; Andreas Meyer zu Vilsendorf; Tania Roskams; Mark Schmidt-Supprian; Klaus Rajewsky; David A Brenner; Michael P Manns; Manolis Pasparakis; Christian Trautwein
Journal:  J Clin Invest       Date:  2005-03-17       Impact factor: 14.808

6.  Nuclear factor {kappa}B inactivation in the rat liver ameliorates short term total warm ischaemia/reperfusion injury.

Authors:  H Suetsugu; Y Iimuro; T Uehara; T Nishio; N Harada; M Yoshida; E Hatano; G Son; J Fujimoto; Y Yamaoka
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

7.  Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis.

Authors:  Montserrat Marí; Francisco Caballero; Anna Colell; Albert Morales; Juan Caballeria; Anna Fernandez; Carlos Enrich; José C Fernandez-Checa; Carmen García-Ruiz
Journal:  Cell Metab       Date:  2006-09       Impact factor: 27.287

8.  Hepatocyte NF-kappaB activation is hepatoprotective during ischemia-reperfusion injury and is augmented by ischemic hypothermia.

Authors:  Satoshi Kuboki; Tomohisa Okaya; Rebecca Schuster; John Blanchard; Alvin Denenberg; Hector R Wong; Alex B Lentsch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-08-31       Impact factor: 4.052

9.  Mitochondrial reactive oxygen species and c-Src play a critical role in hypoxic response in vascular smooth muscle cells.

Authors:  Hiroko Sato; Mahito Sato; Hiroyoshi Kanai; Tsuyoshi Uchiyama; Tatsuya Iso; Yoshio Ohyama; Hironosuke Sakamoto; Junichi Tamura; Ryozo Nagai; Masahiko Kurabayashi
Journal:  Cardiovasc Res       Date:  2005-09-01       Impact factor: 10.787

Review 10.  Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways.

Authors:  Robert F Schwabe; David A Brenner
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-04       Impact factor: 4.052

View more
  26 in total

Review 1.  Crosstalk of reactive oxygen species and NF-κB signaling.

Authors:  Michael J Morgan; Zheng-gang Liu
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

2.  Ethanol extract from portulaca oleracea L. attenuated acetaminophen-induced mice liver injury.

Authors:  Xue-Feng Liu; Cheng-Gang Zheng; Hong-Guang Shi; Gu-Sheng Tang; Wan-Yin Wang; Juan Zhou; Li-Wei Dong
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

Review 3.  Concise review: immunologic lessons from solid organ transplantation for stem cell-based therapies.

Authors:  Andrea Loewendorf; Marie Csete
Journal:  Stem Cells Transl Med       Date:  2013-01-24       Impact factor: 6.940

Review 4.  RORγt+IL-17+ neutrophils play a critical role in hepatic ischemia-reperfusion injury.

Authors:  Zhongming Tan; Runqiu Jiang; Xuehao Wang; Youjing Wang; Ling Lu; Qianghui Liu; Song Guo Zheng; Beicheng Sun; Bernhard Ryffel
Journal:  J Mol Cell Biol       Date:  2013-01-28       Impact factor: 6.216

5.  Ethanol extract of Portulaca Oleracea L. reduced the carbon tetrachloride induced liver injury in mice involving enhancement of NF-κB activity.

Authors:  Hongguang Shi; Xuefeng Liu; Gusheng Tang; Haiyan Liu; Yinghui Zhang; Bo Zhang; Xuezhi Zhao; Wanyin Wang
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

6.  Growth arrest-specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury.

Authors:  Laura Llacuna; Cristina Bárcena; Lola Bellido-Martín; Laura Fernández; Milica Stefanovic; Montserrat Marí; Carmen García-Ruiz; José C Fernández-Checa; Pablo García de Frutos; Albert Morales
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

Review 7.  Innate Immune Regulations and Liver Ischemia-Reperfusion Injury.

Authors:  Ling Lu; Haoming Zhou; Ming Ni; Xuehao Wang; Ronald Busuttil; Jerzy Kupiec-Weglinski; Yuan Zhai
Journal:  Transplantation       Date:  2016-12       Impact factor: 4.939

8.  Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.

Authors:  Shujun Jiang; Zhen Shi; Changyong Li; Chunlei Ma; Xianyong Bai; Chaoyun Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

9.  Regulation of molecular pathways in ischemia-reperfusion injury after liver transplantation.

Authors:  Ricardo C Gehrau; Valeria R Mas; Catherine I Dumur; Danielle E Ladie; Jihee L Suh; Samuel Luebbert; Daniel G Maluf
Journal:  Transplantation       Date:  2013-11-27       Impact factor: 4.939

Review 10.  Apoptosis and necrosis in the liver.

Authors:  Maria Eugenia Guicciardi; Harmeet Malhi; Justin L Mott; Gregory J Gores
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.